Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health’s wearable therapy is essential tremor, a disease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
Therapeutic Pipeline Highlight: Essential Tremor
Essential tremor (ET) is a common movement disorder affecting over 7 million Americans and millions more worldwide. The condition is marked by hand tremors that make it difficult, if not impossible, to perform daily activities like eating, drinking, and writing. Cala Health is working on a solution that retunes the nervous system in order to relieve the symptoms of ET. Cala Health is striving to put patients in control of their tremor — without the need for invasive brain surgery or drugs. Cala Health supports the International Essential Tremor Foundation (IETF) and works to connect people living with essential tremor to new therapies. For more information about essential tremor, visit essentialtremor.org.
